Main and papain-like proteases as prospective targets for pharmacological treatment of coronavirus SARS-CoV-2
LV Yevsieieva, KO Lohachova, A Kyrychenko… - RSC …, 2023 - pubs.rsc.org
The pandemic caused by the coronavirus SARS-CoV-2 led to a global crisis in the world
healthcare system. Despite some progress in the creation of antiviral vaccines and mass …
healthcare system. Despite some progress in the creation of antiviral vaccines and mass …
Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF. 5 lineage in Tokyo, Japan
B Jin, R Oyama, Y Tabe, K Tsuchiya, T Hando… - Frontiers in …, 2023 - frontiersin.org
There has been a decreasing trend in new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) cases and fatalities worldwide. The virus has been evolving, indicating the …
(SARS-CoV-2) cases and fatalities worldwide. The virus has been evolving, indicating the …
[HTML][HTML] Antibody Responses in SARS-CoV-2-Exposed and/or Vaccinated Individuals Target Conserved Epitopes from Multiple CoV-2 Antigens
D Yao, RS Patel, A Lam, Q Glover… - International Journal of …, 2024 - mdpi.com
There is a need to investigate novel strategies in order to create an effective, broadly
protective vaccine for current and future severe acute respiratory syndrome coronavirus 2 …
protective vaccine for current and future severe acute respiratory syndrome coronavirus 2 …
Bioinformatic Analysis of Missense Mutations Affecting ACE2–SARS-CoV-2 Complexes
V Mahase - 2023 - search.proquest.com
Discovering ACE2 as the receptor for SARS-CoV-2 Spike (S) has catalyzed an influx of
research to understand infection pathology and develop drugs. Nonetheless, disparities in …
research to understand infection pathology and develop drugs. Nonetheless, disparities in …